Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS scoreJoerg Hasford, Rüdiger Hehlmann, François Guilhot et al.|Blood|2011Cited by 497
Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemiaMarkus Pfirrmann, Bengt Simonsson, Michele Baccarani et al.|Leukemia|2015Cited by 298
The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European CountriesVerena Hoffmann, Rüdiger Hehlmann, Michele Baccarani et al.|Leukemia|2015Cited by 255